Mesothelioma Legal News

Five Prime Therapeutics Provides Update on FP-1039 Clinical Program

Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today provided an update on GlaxoSmithKline’s ongoing Phase 1b clinical trial …

FACT Act Would Expose Asbestos Victims Personal Information

The FACT Act moves through Congress this week, which could result in asbestos victims’ personal data and medical histories getting published on the Internet.